NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Wuhan Hiteck Biological Pharma Co. Ltd (SHE: 300683)
300683 Technical Analysis
5
As on 17th Jul 2025 300683 SHARE Price closed @ 32.85 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 24.97 & Strong Buy for SHORT-TERM with Stoploss of 27.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300683SHARE Price
Open | 29.17 | Change | Price | % |
High | 34.25 | 1 Day | 3.50 | 11.93 |
Low | 29.15 | 1 Week | 6.19 | 23.22 |
Close | 32.85 | 1 Month | 6.36 | 24.01 |
Volume | 13225125 | 1 Year | -0.07 | -0.21 |
52 Week High 34.56 | 52 Week Low 19.90 |
SHE China Most Active Stocks
002131 | 3.71 | -1.33% |
000617 | 9.19 | 3.26% |
000725 | 4.04 | 2.28% |
000903 | 3.30 | -4.90% |
002640 | 5.69 | 5.18% |
000100 | 4.61 | 3.13% |
000727 | 2.45 | 6.52% |
000564 | 2.35 | 0.43% |
300059 | 23.60 | 0.77% |
000981 | 2.13 | 0.00% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
300683 Daily Charts |
300683 Intraday Charts |
Whats New @ Bazaartrend |
300683 Free Analysis |
|
300683 Important Levels Intraday
RESISTANCE | 42.68 |
RESISTANCE | 39.53 |
RESISTANCE | 37.58 |
RESISTANCE | 35.63 |
SUPPORT | 30.07 |
SUPPORT | 28.12 |
SUPPORT | 26.17 |
SUPPORT | 23.02 |
300683 Forecast July 2025
4th UP Forecast | 51.04 |
3rd UP Forecast | 45.21 |
2nd UP Forecast | 41.6 |
1st UP Forecast | 37.99 |
1st DOWN Forecast | 27.71 |
2nd DOWN Forecast | 24.1 |
3rd DOWN Forecast | 20.49 |
4th DOWN Forecast | 14.66 |
300683 Weekly Forecast
4th UP Forecast | 43.66 |
3rd UP Forecast | 40.19 |
2nd UP Forecast | 38.05 |
1st UP Forecast | 35.91 |
1st DOWN Forecast | 29.79 |
2nd DOWN Forecast | 27.65 |
3rd DOWN Forecast | 25.51 |
4th DOWN Forecast | 22.04 |
300683 Forecast2025
4th UP Forecast | 65.19 |
3rd UP Forecast | 54.82 |
2nd UP Forecast | 48.41 |
1st UP Forecast | 42 |
1st DOWN Forecast | 23.7 |
2nd DOWN Forecast | 17.29 |
3rd DOWN Forecast | 10.88 |
4th DOWN Forecast | 0.51 |
Wuhan Hiteck Biological Pharma Co. Ltd ( SHE China Symbol : 300683 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300683 Other Details
Segment | EQ | |
Market Capital | 5147904512.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
300683 Address
![]() |
300683 Latest News
300683 Business Profile
Wuhan Hiteck Biological Pharma Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of biological engineering products and freeze-dried powder injection primarily in China. Its products include Jinlujie 20ug, a mouse nerve growth factor for injection; and recombinant allosteric human tumor necrosis factor, which is in phase III clinical trial used for the treatment of apoptosis. The company offers its products in the field of nervous system and oncology. Wuhan Hiteck Biological Pharma Co., Ltd. is based in Wuhan, China. Address: Hite Science and Technology Park, Wuhan, China, 430056
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service